Drugs / prednisonlone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02936375 Background | Sep 2017 → Nov 2020 | lupus nephritis | RenJi Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | prednisonlone | “Prednisone, methylprednisolone or prednisonlone, once a day, orally administrated” NCT02936375 ↗ |
| Route | Oral | “Prednisone, methylprednisolone or prednisonlone, once a day, orally administrated” NCT02936375 ↗ |